The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pancreatic cancer and diabetes: The effects of race and genes.
 
Michael Shu
No Relationships to Disclose
 
Katie Moreland
No Relationships to Disclose
 
Olugbenga Olanrele Olowokure
No Relationships to Disclose
 
Tahir Latif
No Relationships to Disclose
 
Adam Rojan
Research Funding - Isofol Medical (Inst); Merck (Inst)
 
Gregory Wilson
No Relationships to Disclose
 
Sameer H. Patel
No Relationships to Disclose
 
Jeff Sussman
No Relationships to Disclose
 
Syed Ahmad
No Relationships to Disclose
 
Jianmin Pan
No Relationships to Disclose
 
Shesh Rai
No Relationships to Disclose
 
Davendra Sohal
Honoraria - Foundation Medicine
Consulting or Advisory Role - AADi; Ability Pharma; AstraZeneca/MedImmune; Bayer; Elevar Therapeutics; Totus Medicines; TransThera Sciences (Nanjing), Inc.; Valar Labs
Speakers' Bureau - AstraZeneca; Genentech; Incyte; Seagen
Research Funding - Ability Pharma (Inst); Amgen (Inst); Apexigen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bexion (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Hengrui Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); NextCure (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Triumvira Immunologics, Inc (Inst)
Travel, Accommodations, Expenses - Ability Pharma